Fundraising Fox
/Companies
Sign in

Nanostring

acquired by Bruker

4 known investors

Find your way into Nanostring

Sign up to find every way you can get introduced to Nanostring

  • Your email: who you already know at Nanostring, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nanostring team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Acquired by Bruker Corporation April 2024 · $392.6M (approximately $392.6 million in cash for substantially all assets) · source ↗

NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.

BiotechDeep TechHealthtechMedical Devices

Investors · 4

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · Not right? Tell us

Kicker Ventureslisted by Kicker VenturesSan Francisco · $100K – $1M

How we know: Kicker Ventures's portfolio page · Not right? Tell us

Owl Capitallisted by Owl Capitalvia Jennifer Fonstad · inferred

Related companies · 2

OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
IDbyDNAScalable, high throughput DNA sequencing platforms.

Companies working in the same space as Nanostring.

Frequently asked questions

What does Nanostring do?
NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
Who are Nanostring's investors?
Nanostring's investors include Aspect Ventures, Foresite Capital, Kicker Ventures, Owl Capital.
Who acquired Nanostring?
Nanostring was acquired by Bruker.